In my recently published book, “The Biopolitics of Beauty,” I question the idea which humanitarianism can be the driving force of plastic surgery in Brazilian public hospitals.
Burn victims in addition to individuals with congenital deformities were once the main beneficiaries of plastic surgery in these hospitals. yet at many of the clinics where I carried out my research, nearly 95 percent of all those surgeries have become purely aesthetic. I documented hundreds of instances where surgeons in addition to residents purposely blurred the boundaries between reconstructive in addition to aesthetic procedures to get them approved by the government.
Since most of the surgeries in public hospitals are carried out by medical residents who are still training to be plastic surgeons, they have a vested interest in learning aesthetic procedures – skills which they’ll be able to later market as they open private practices. yet they have very little interest in learning the reconstructive procedures which actually improve a bodily function or reduce physical pain.
Additionally, most of Brazil’s surgical innovations are first tested by plastic surgeons in public hospitals, exposing those patients to more risks than wealthier patients. Working-class patients are understood as subjects for inquiry, in addition to I spoke to the little yet significant number who were very unhappy with the results of their surgery.
Take one woman I interviewed named Renata. The medical resident who operated on her left her with deformed breasts in addition to uneven nipples. She also developed severe infections which took months to heal in addition to left significant scars. She considered suing the doctor, yet discovered she would certainly need a costly expert medical evaluation. She also knew which the Brazilian legal system would certainly likely grant her very little in terms of damages. inside end, she settled for another free surgery, one which she hoped would certainly provide a better result in addition to leave her less unhappy.
This kind of was a typical story among low-income patients which were harmed by plastic surgeons. Their lack of financial resources made the idea nearly impossible for them to find any justice if anything went wrong, so they assumed all of the risk.
Plastic surgeons, on the various other hand, are eager to try completely new techniques if they seem promising, no matter how risky they might be. A technique known as “bioplastia,” for example, consists of injecting a liquid compound called PMMA into the body in order to permanently reshape a patient’s features. The compound, which can be similar to acrylic glass, doesn’t cause problems in most patients. yet in a little minority the idea causes very severe complications, including necrosis of facial tissue. Yet many doctors I interviewed strongly defended the technique, claiming the idea was a phenomenal tool which allowed them to transform the human body. Risk, they argued, was inherent in any surgical procedure.
Around the globe, Brazilian plastic surgeons are known as the best in their field, in addition to they gain global recognition for their daring completely new techniques. During an international plastic surgery conference in Brazil, an American surgeon I interviewed told me, “Brazilian surgeons are pioneers… You know why? Because [in Brazil] they don’t develop the institutional or legal barriers to generate completely new techniques. They can be creative as they want to be.”
In various other words, there are few regulations in place which could protect low-income patients via malpractice.
In a country where appearance can be seen as central to one’s very citizenship, patients agree to becoming experimental subjects in exchange for beauty. yet the idea’s often a choice made under duress, in addition to the consequences can be dire.
Commentary by Alvaro Jarrin, an Assistant Professor of Anthropology at College of the Holy Cross. He can be also a contributor at The Conversation, an independent source of news in addition to views via the academic in addition to research community.
For more insight via CNBC contributors, follow